WAYNE, Pa.--(BUSINESS WIRE)--Nov. 16, 2017--
Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the
registered public offering, subject to market and other conditions, of
$500.0 million aggregate principal amount of senior notes due 2027 (the
“Notes”). The interest rate and other terms of the Notes will be
determined at pricing.
The Notes will be guaranteed by each of Teleflex’s existing and future
wholly-owned domestic subsidiaries that is a guarantor or other obligor
under its credit agreement and by certain of Teleflex’s other
wholly-owned subsidiaries.
Teleflex intends to use the net proceeds from the offering to repay
approximately $491.2 million of borrowings under its revolving credit
facility.
J.P. Morgan, BofA Merrill Lynch and PNC Capital Markets LLC are acting
as joint book-running managers for this offering.
The Notes will be issued pursuant to an effective shelf registration
statement filed with the Securities and Exchange Commission (“SEC”) on
Form S-3, as amended. The offering is being made only by means of a
prospectus supplement and accompanying prospectus. You may obtain these
documents for free by visiting EDGAR on the SEC website at www.sec.gov.
Alternatively, copies may also be obtained from J.P. Morgan Securities
LLC by calling (866) 803-9204, from Merrill Lynch, Pierce, Fenner &
Smith Incorporated at 200 North College Street, 3rd Floor,
Charlotte, NC 28255-0001 Attn: Prospectus Department or from PNC Capital
Markets LLC at 225 Fifth Avenue, Three PNC Plaza 10th Floor, Pittsburgh,
PA 15222 or by calling (855) 881-0697. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy the
Notes, nor shall there be any sale of the Notes, in any jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
jurisdiction.
ABOUT TELEFLEX INCORPORATED
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation – a relentless pursuit of identifying unmet clinical
needs – to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference..
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®,
Rusch® and Weck® – trusted brands united by a common sense of purpose.
CAUTION CONCERNING FORWARD-LOOKING INFORMATION
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management’s current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our
prospectus supplement and accompanying prospectus and our filings with
the SEC, including our Annual Report on Form 10-K filed with the SEC on
February 23, 2017 and quarterly reports on Form 10-Q filed with the SEC
on May 4, 2017, August 3, 2017 and November 2, 2017, which can be
obtained on the SEC’s website at http://www.sec.gov.
We undertake no obligation to publicly update or revise any
forward-looking statements, except as otherwise specifically stated by
us or as required by law or regulation.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171116005786/en/
Source: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice
President, Investor Relations
610-948-2836